Fevertree Drinks (FV8) AI Stock Analysis

4 Followers

Fevertree Drinks

(Frankfurt:FV8)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Very low leverageVery low leverage gives Fever-Tree substantial financial flexibility to fund marketing, innovation and potential acquisitions without depending heavily on borrowing. This strengthens resilience through operating volatility and supports continued shareholder returns while preserving capacity for growth investments.

Negative Factors

Revenue and margin deteriorationThe recent decline in revenue and materially lower margins weaken the quality of Fever-Tree’s earnings profile compared with earlier years. Unless growth and profitability recover, reduced operating leverage could limit earnings compounding and make future performance more dependent on successful execution.

Fevertree Drinks (FV8) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.36B
Dividend Yield: 1.85%
Average Volume (3M): 543
Price to Earnings (P/E): 43.3
Beta (1Y): 0.56
Revenue Growth: -1.65%
EPS Growth: -0.63%
Country: Germany
Employees: 285
Sector: Consumer Defensive
Sector Strength: 62
Industry: Beverages - Non-Alcoholic

Fevertree Drinks Business Overview & Revenue Model

Company Description

Fevertree Drinks Plc, together with its subsidiaries, specializes in crafting and distributing premium mixer beverages across the United Kingdom, the United States, Europe, and other international markets. Its diverse product portfolio includes popul...

Fevertree Drinks Earnings Call Summary

Earnings Call Date:Sep 10, 2026(Q2-2026)|% Change Since:19.67%|Next Earnings Date:Mar 30, 2027

Earnings Call SentimentPositive

The call was strongly positive. Management reported broad-based first-half growth, improving margins and EPS, accelerating U.S. momentum, successful diversification, strong cash generation, and confidence in a circa 60% EBITDA uplift over the next two years. The main challenges were the expected short-term U.S. margin impact from elevated marketing investment, the GBP 2.6 million EPR provision, U.K. on-trade challenges, European revenue phasing, and delayed working-capital benefits from U.S. onshoring.

Positive Updates

Strong First-Half Group Performance

Brand revenue increased by 8% at constant currency, with growth across every key region. The U.S. grew 11%, Europe grew 10%, the U.K. returned to growth, and the rest of the world made good progress.

Negative Updates

U.S. EBITDA Margin Decline

U.S. EBITDA margin reduced as expected, largely reflecting up-weighted marketing investment. Management said incremental U.S. marketing investment is expected to moderate to more typical levels over the medium term.

Company Guidance

For FY 2026, Fever-Tree expects U.S. revenue growth to accelerate as the year progresses, the rest of the group to deliver good underlying growth, reported revenue in Europe to be impacted as phasing benefits from the first half of the year unwind, and EBITDA to be in line with expectations; U.S. tariff refunds received in the second half will offset the full-year impact of the incremental GBP 2.6 million EPR provision, working capital will be similar year-on-year and significantly below historic levels, and the company remains confident of delivering high teens, 20% growth in the U.S. next year, with U.S. and group profitability expected to see a step change in 2027 and 2028, supporting consensus expectations of the circa 60% uplift in EBITDA over the next two years and at least GBP 100 million of free cash flow across 2027 and 2028; group EBITDA margin is expected to move from about 12.5% this year to high 14%-15%.

Fevertree Drinks Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

DE:FV8 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:NICL	82Outperform	GBP 387.63M	16.69	24.74%	3.59%	2.73%	37.06%
GB:CCH	72Outperform	GBP 15.48B	18.77	25.10%	2.37%	12.76%	12.70%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GB:BAG	61Neutral	GBP 659.70M	14.59	13.40%	3.19%	6.88%	-5.66%
GB:CDGP	55Neutral	GBP 81.10M	231.58	0.97%	―	22.07%	―
GB:CCR	52Neutral	GBP 386.75M	108.42	0.81%	4.64%	-2.97%	-79.32%

* Consumer Defensive Sector Average

Performance Comparison

DE:FV8 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:FV8	Fevertree Drinks PLC	10.92	1.68	18.16%
GB:BAG	A G Barr	598.00	-33.96	-5.37%
GB:CCH	Coca Cola HBC	4330.00	761.17	21.33%
GB:NICL	Nichols plc	1085.00	94.14	9.50%
GB:CCR	C&C Group Plc	104.20	-23.47	-18.38%
GB:CDGP	Chapel Down Group plc	44.00	6.00	15.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Fevertree Drinks AI Stock Analysis